drugset / Trial / NCT04512950

Crystalloid FLUID Choices for Resuscitation of Hospitalized Patients

NCT04512950

Phase 4 Completed 43626 enrolled Ottawa Hospital Research Institute
RandomizedCrossoverOpen-labelTreatment

Summary

The aim of the FLUID Trial is to conduct a pragmatic, multi-centre, open label randomized cluster cross-over trial (RCT) to determine whether fluid administration with 0.9% saline as compared to Ringer's lactate decreases death or re-admission to hospital with 90 days of the index admission.

Timeline

Start
2016-08-15
Primary completion
2020-06-13
Completion
2020-06-13

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ringer's Lactate Other / unclassified Intravenous
Comparator sodium chloride Unknown 0.9 % Intravenous

Indications

No indication recorded.